US Patent 11920136 Transglutaminase-mediated conjugation
Patent 11920136 was granted and assigned to Tallac Therapeutics on March, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+39 properties)
Article (+207 characters)
US Patent 11920136 Transglutaminase-mediated conjugation
Article
Patent abstract
The present disclosure provides for antibody-oligonucleotide conjugates, methods of preparation thereof, and methods of use thereof. Also provided are related compounds, compositions and kits.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Bang Janet Sim0
Curt W. Bradshaw0
Edward HyungSuk Ha0
Hong I. Wan0
Jaume Pons0
Son Lam0
Sukumar Sakamuri0
Tracy Chia-Chien Kuo0
Date of Patent
March 5, 2024
0Patent Application Number
171875790
Date Filed
February 26, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11920136 Transglutaminase-mediated conjugation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.